SELECT MEDICAL HOLDINGS CORP

Select Medical Holdings Corp has a debt-to-equity ratio of 1.05, indicating a moderate reliance on debt financing, while its current ratio of 1.15 suggests limited short-term liquidity cushion. The company's return on equity of 2.51% and return on assets of 0.73% are below the industry median for healthcare facilities, reflecting underperformance in capital efficiency and asset utilization. The company's revenue is concentrated across three segments: Critical Illness Recovery Hospital (58% of total revenue), Rehabilitation Hospital (22%), and Outpatient Rehabilitation (20%). Geographically, the majority of revenue is derived from the United States, with no material international exposure. Outlook for FY 2026 indicates a 3.2% revenue decline year-over-year, driven by reduced reimbursement rates and lower patient volumes in critical care units. The company's operating cash flow of $37.86 million in Q1 2026 is insufficient to cover long-term debt obligations of $1.84 billion, raising concerns about long-term liquidity. Risk assessment highlights medium dilution potential, with recent filings referencing equity financing commitments and merger-related obligations. The company's liquidity risk is elevated due to a current ratio near the minimum comfort range and negative net cash after debt. Recent events include a proposed merger with a cash consideration of $16.50 per share, partially funded by an $880 million equity commitment. The company also disclosed adoption of ASU 2024-03, which will enhance expense disaggregation disclosures in future filings.